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PiroxicamPreviously studies have demonstrated that Cl−/HCO3− exchange was inhibited during chronic intestinal in-
ﬂammation secondary to decrease in the afﬁnity of the exchanger for Cl− rather than the number of trans-
porters. Arachidonic acid metabolites (AAM) are elevated in the mucosa of the chronically inﬂamed small
intestine. However, their role in the alteration of Cl−/HCO3− during chronic enteritis was unknown. Inhibition
of AAM formation with arachidonyl triﬂuoro methylketone (ATMK) in chronically inﬂamed rabbit intestine
reversed the diminished Cl−/HCO3− exchange activity. Kinetics studies showed that the reversal was second-
ary to restoration of the altered afﬁnity of transporter. Downstream regulation of Cl−/HCO3− inhibition by
AAM was determined to be by the cyclooxygenase pathway since only inhibition of cyclooxygenase with
piroxicam treatment reversed the inhibited Cl−/HCO3
− exchange. Further, DRA was shown to be the primary
Cl−/HCO3− exchanger in villus cells. Kinetics and molecular studies indicated that the mechanism of inhibi-
tion of Cl−/HCO3− exchange by cyclooxygenase pathway metabolites was secondary to diminished afﬁnity
of the transporter for Cl− without a change in DRA BBM expression. Thus our data indicated that cyclooxy-
genase pathway metabolites mediate the inhibition of DRA during chronic intestinal inﬂammation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The most common and disabling morbidity of human inﬂammatory
bowel disease is diarrhea. It results as a result of altered absorption and
secretion of electrolytes and ﬂuid by intestinal epithelial cells. Neutral
NaCl absorption occurs in the mammalian small intestine through
coupled Na/H and Cl−/HCO3− exchange on the brush border membrane
(BBM) of absorptive villus cells. In an animal model of chronic small in-
testinal inﬂammation which has many characteristics of human IBD,
we have demonstrated the inhibition of coupled NaCl absorption [1].
The mechanism is secondary to a reduction in Cl−/HCO3− exchange,
without a change in Na/H exchange in the BBMof villus cells [2]. Howev-
er, the identity and the speciﬁc immune regulation of Cl−/HCO3− ex-
change in the chronically inﬂamed rabbit intestine are not known.
Various Cl−/HCO3− exchangers (SLC26 family), PAT1, DRA and Pendrin
have been demonstrated to have selective and limited tissue distribution.
Further, PAT1 (SLC26A6) and DRA (SLC26A3) have been reported in the
BBM of intestinal epithelia [3–5]. Nevertheless, the major Cl−/HCO3− ex-
changer that is down regulated in the chronically inﬂamed rabbit small
intestine is not known.
In IBD (e.g. Crohn's disease) alterations in absorption of electrolytes
and water causing diarrhea is mediated by inﬂammatory mediatorsram).
rights reserved.known to be elevated in the mucosa of the chronically inﬂamed intes-
tine [6–9]. Inhibition of Cl−/HCO3− exchange and stimulation of luminal
Cl− secretion is one of the major transport alterations observed during
intestinal inﬂammation [10]. Arachidonic acid metabolites have been
shown to be elevated in the mucosa of inﬂammatory bowel disease
[11] and in ulcerative colitis [12,13] and may be important for the ob-
served diminished Cl−/HCO3− exchange [14].
In the rabbit model of chronic intestinal inﬂammation multiple
unique alterations in electrolyte and nutrient transport processes have
been shown to occur [1,15,16]. For example, the two distinct anion ex-
changers, Cl−/HCO3− and SCFA/HCO3− on the BBM of villus cells in the
rabbit small intestine are uniquely regulated in the chronically inﬂamed
intestine.While, both Cl−/HCO3− and SCFA/HCO3− exchange are inhibited
in the chronically inﬂamed intestine, their mechanisms of alteration are
different. Cl−/HCO3− exchange is diminished secondary to a reduction
in the afﬁnity of the exchanger for Cl− without a change in transporter
numbers during chronic enteritis. In contrast, SCFA/HCO3− exchange is
reduced secondary to a reduction in exchanger numbers without a
change in the afﬁnity of the transporter. However, it is not knownwheth-
er a given immune-inﬂammatory mediator pathway is responsible for
these unique alterations of anion exchangers seen during chronic
enteritis.
Immune-inﬂammatory mediators such as metabolites of arachidonic
acid are known to inﬁltrate intestinal mucosa during intestinal inﬂamma-
tion [17]. Cytosolic phospholipase A2 (PLA2) catalyzes the release of
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metabolites (AAM) formed by both the cyclooxygenase (COX) and
5-lipoxygenase (LOX) pathways may contribute to the clinical diarrhea
of IBD [17–20]. In fact, AAMhave been reported to stimulate electrolyte se-
cretion and inhibit NaCl absorption in animals with intestinal inﬂamma-
tion [9,21]. But, it is not known whether prevention of AA biosynthesis
or the subsequent formation of AAM via COX and/or LOX pathways may
reverse the alteration in NaCl absorption during chronic intestinal
inﬂammation.
Therefore, in this study we ﬁrst studied the in vivo effect of
arachidonyl triﬂuoro methylketone (ATMK) a potent inhibitor of
PLA2 biosynthesis of AA [22]. Then to delineate whether the AAM of
COX and/or LOX pathways regulate Cl−/HCO3−exchange, we treated
rabbis with chronically inﬂamed with piroxicam and MK-886 to in-
hibit the COX and LOX pathways respectively. Finally, we also deter-
mined the molecular identity of the villus cell Cl−/HCO3−exchanger
in the rabbit ileum.
2. Materials and methods
2.1. Induction of chronic inﬂammation
Chronic intestinal inﬂammation was induced in pathogen-free
New Zealand White male rabbits as described earlier [1]. Brieﬂy, rab-
bits weighing 1.8–2.0 kg were intragastrically inoculated with
Eimeria magna oocytes (~10,000 per animal) or sham inoculated
with 0.9% NaCl (control animals). Animals inoculated with oocytes
developed chronic intestinal inﬂammation on 13–15 days post inocu-
lation. Only enterocytes from those animals that were histologically
conﬁrmed for chronic ileal inﬂammation were utilized for experi-
ments. All the sham inoculated animals did not show any evidence
of intestinal inﬂammation.
2.2. Drug treatment
Normal and inﬂamed rabbits were treated with ATMK (3 mg/kg),
piroxicam (10 mg/kg), or MK-886(0.5 mg/kg) (on days 12 and 13
post inoculation) by intramuscular injection. Animals were eutha-
nized with 100 mg/kg of pentobarbital sodium through the ear vein
according to protocol approved by the West Virginia University
Animal Care Use Committee. ATMK, piroxicam and MK-886 were
obtained from Sigma-Aldrich, St. Louis, MO, USA.
2.3. Cell isolation
Villus and crypt cells were isolated from the intestine by a calcium
chelation technique as previously described [23,24]. Previously
established criteria were utilized to validate separation of villus and
crypt cells. Some of these criteria included marker enzymes (e.g., thy-
midine kinase, alkaline phosphatase levels), transporter speciﬁcity
(e.g., Na/H on the BBM of villus, but not crypt cells), intracellular pH
(e.g., intracellular pH is higher in crypt cells compared with villus),
and morphological differences (e.g., villus cells are larger and with
better developed BBM compared with crypt cells). Viability of the iso-
lated villus cells was determined by trypan blue exclusion. Isolated
cells were then used for BBM vesicle (BBMV) preparation.
2.4. BBMV preparation
BBMV from rabbit ileal villus cells were prepared by CaCl2 precip-
itation and differential centrifugation as previously described [25].
BBMV were resuspended in a medium appropriate to each experi-
ment. BBMV purity was assured with marker enzyme enrichment
(e.g., alkaline phosphatase).2.5. Uptake studies in villus cell BBMV
BBMV uptake studies were performed by the rapid-ﬁltration tech-
nique as previously described [1,23]. Cl−/HCO3− exchange experi-
ments were performed by resuspending BBMV in vesicle medium
containing 105 mM N-methyl-D-glucamine (NMG) gluconate,
50 mM HEPES-Tris pH7.5 and either 50 mM KHCO3− gassed with
5%CO2-95%N2 or 50 mM potassium gluconate gassed with 100% N2.
The reaction was started by adding 5 μl of vesicle to 95 μl reaction
mix containing 5 mM NMG 36Cl−, 149.7 mM potassium gluconate,
50 mM MES-Tris pH 5.5 and either 0.3 mM KHCO3− gassed with 5%
CO2-95% N2 or 150 mM potassium gluconate gasses with 100% N2.
1 mM 4,4-Diisothiocyanatostilbene-2,2-disulfonic acid disodium salt
(DIDS), a potent anion exchange inhibitor, was added to the reaction
mix when relevant. Theuptakewas stopped at desired timewith ice cold
stop solution containing 50 mM HEPES-Tris buffer (pH7.5), 0.10 mM
MgSO4, 50 mM potassium gluconate and 100 mM NMG gluconate. The
mixture was ﬁltered on 0.45 μm Millipore (HAWP) ﬁlters and washed
twice with 5 ml ice-cold stop solution. Filters with BBMVwere dissolved
in 5 ml scintillation ﬂuid (Ecoscint, National Diagnostics), and radioactiv-
ity was determined in a Beckman 6500 Beta Scintillation Counter. Results
were calculated as the HCO3 dependent DIDS sensitive Cl− uptake.
2.6. Immunohistochemistry for DRA
Normal and chronically inﬂamed rabbit intestinal tissue was ﬁxed
in 10% (vol/vol) neutral-buffered formalin (Richard-Allan Scientiﬁc,
Kalamazoo, MI) and embedded in parafﬁn. Sections (4 μm) were
obtained by a microtome and were mounted on glass slides. Parafﬁn
was removed from the sections by incubating the slides with xylene,
and sections were hydrated gradually by incubating with graded eth-
anol. Antigen retrieval was performed by incubating the sections with
10 mM sodium citrate buffer, pH 6, at 95 °C for 5 min. Nonspeciﬁc
binding sites in the tissue sections were blocked by incubation with
goat serum for 1 hour at room temperature. The tissue sections
were then incubated overnight with DRA primary antibody. Excess
antibody was removed by washing with phosphate buffered saline
(PBS) and incubated with goat anti-chicken IgG secondary antibody
coupled to FITC (Santa Cruz Biotechnology, Santa Cruz, CA) at room
temperature for 1 hour. Excess secondary antibody was removed by
washing with PBS and the tissue sections were mounted by use of
ProLong Gold Antifade Reagent (Invitrogen Life Technologies, Carls-
bad, CA, USA). Finally, the signal generated by FITC was observed
under Zeiss LSM510 confocal microscope and photographed.
2.7. Real time PCR (RTQ-PCR) for DRA
Total RNA was isolated from normal, inﬂamed and treated rabbit
intestinal villus cells using Trizol reagent (Invitrogen Life Technolo-
gies, Carlsbad, CA, USA) and RTQ-PCR was performed by a two step
method. First–strand cDNA synthesis from total RNA was performed
using Superscript™ III from Invitrogen Life Technologies using an
equal mixture of oligo (dT) primer and random hexamer. The
cDNAs generated were used as templates for RTQ- PCR. The reactions
were performed using TaqMan universal PCR master mix from Ap-
plied Biosystems on an ABI 7300 Real Time PCR system according to
the manufacturer- recommended protocol. The primer and probe se-
quences used for DRA RTQ-PCR are given below.
Forward primer — 5′-TGGCACTTCTAAACACATCTCTG-3′
Reverse primer — 5′-TCGTCTGGGGCTAATCTCAC-3′
TaqMan probe — 5′ FAM-TCCATTTCCGGTTCTGAGCATGATGGTG‐
TAMRA 3′
RTQ-PCR for β-actin, using speciﬁc primers for rabbit gene, was run
along with the DRA-speciﬁc RTQ-PCR as an endogenous control under
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expression levels of DRA between the individual samples. The
sequences of the rabbit β-actin primers and probes are given below:
Forward primer — 5′ GCTATTTGGCGCTGGACTT 3′
Reverse primer — 5′ GCGGCTCGTAGCTCTTCTC 3′
TaqMan Probe— 5′ FAM-AAGAGATGGCCACGGCCGCGAAC-TAMRA 3′
Final concentrations of primer and probe for both DRA and β-actin
were 500 nM and 100 nM respectively. The parameters of Real-time
PCR were 95 °C for 15 seconds and 62 °C for 1 minute. All experi-
ments were performed in triplicate and repeated at least thrice.2.8. Western blot studies for DRA
Polyclonal antibody against rabbit DRAwas raised in chicken by using
the custom antibody services provided by Invitrogen Life Technologies.
Western blotting for DRA was performed according to the standard pro-
tocols. Brieﬂy, BBM from villus cells of normal, inﬂamed and treated rab-
bit ileum were solubilized in RIPA buffer (50 mM Tris–HCl pH 7.4, 1%
Igepal, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM Na3VO4, 1 mM
NaF) containing protease inhibitor cocktail (Sigma-Aldrich, St. Louis,
MO). Equal volume of 2× SDS/sample buffer (100 mMTris, 25% glycerol,
2%SDS, 0.01% bromophenol blue, 10% 2- mercapto ethanol, pH 6.8) was
added and the proteins were separated on a 4–20% Ready Gel (Bio-Rad
Laboratories, Hercules, CA, USA). The separated proteins were trans-
ferred on to polyvinylidenediﬂuoride membrane and probed with the
primary antibody (Ab) against rabbit DRA Ab at a dilution of 1:2000
and incubated overnight at 4 °C. Rabbit anti-chicken secondary antibody
coupled to horseradish peroxidase was used to monitor the binding
of the primary antibody. ECL western blotting detection reagent
(GE Healthcare Biosciences, Piscataway, NJ, USA) was used to detect
the DRA speciﬁc signal. The chemiluminescent signal was quantitated
by using a Molecular Dynamics (Sunnyvale, CA, USA) densitometric
scanner. All experiments were performed in triplicate.2.9. Data presentation
Results presented represent means±SE of experiments performed
and calculated using GraphPadInstat program. All uptakes were done
in triplicate. Student t-test was performed for statistical analysis and
is signiﬁcant if the p value is b0.05. The n number in each ﬁgure repre-
sents the number of animals with respective conditions that were
studied.Fig. 1. Effect of ATMK treatment on Cl−/HCO3− exchange in villus cell BBMV from the norma
during chronic intestinal inﬂammation. A: Inhibited Cl−/HCO3− exchange in chronically in
*pb0.05. B: ATMK treatment signiﬁcantly stimulated Cl−/HCO3− exchange in normal rabbit3. Results
3.1. Effect of inhibition of AA release on Cl−/HCO3
− exchange
Cl−/HCO3− exchange, deﬁned as HCO3−-dependent and DIDS-
sensitive Cl uptake, is diminished in villus cell BBMV from the chron-
ically inﬂamed rabbit intestine. In order to determine whether arachi-
donic acid metabolites are responsible for the decrease in Cl−/HCO3−
activity during chronic inﬂammation, rabbits were treated in vivo
with ATMK. ATMK treatment reversed Cl−/HCO3− exchange inhibi-
tion in villus cell BBMV (756±55 pmol/mg protein/min in control,
159±22 in inﬂamed, and 678±47 in inﬂamed treated with ATMK,
pb0.01, n=5; Fig. 1A). Interestingly, ATMK treatment stimulated
Cl−/HCO3− exchange in villus cell BBMV from normal rabbit intestine
(1438±114 pmol/mg protein/min in ATMK treated, pb0.05, n=5;
and Fig. 1B). These data indicate that blocking the release of AA reverses
the inhibition of Cl−/HCO3− activity during chronic inﬂammation.3.2. Kinetic studies for Cl−/HCO3
− exchange during inhibition
of AA release
Previous studies from our lab have shown that HCO3−-dependent
and DIDS-sensitive 36Cl uptake in BBMVwas linear for at least 10 sec-
onds, hence uptake studies for various concentrations were carried
out at 3 seconds. Fig. 2A shows 36Cl uptake in BBMV as a function of
varying concentrations of extra-vesicular Cl. As the concentration of
extra-vesicular Cl was increased, 36Cl uptake was stimulated and sub-
sequently became saturated in all conditions. Kinetic parameters
demonstrated that in the chronically inﬂamed intestine inhibition of
Cl−/HCO3− exchange activity occurs as a result of an increase in the
Km, and in vivo ATMK treatment revered this change (Km for Cl− up-
take in villus cell BBMV was 20.6±1.0 mM in normal, 51.3±1.4 in
inﬂamed, 21.7±1.2* inﬂamed+ATMK, n=3, pb0.05). The maximal
rate of uptake (Vmax) was unaffected in all conditions (Vmax was
43.5±1.5 nmol/mg protein min in normal, 45.4±1.3 inﬂamed,
46.2±1.4 inﬂamed+ATMK; n=3). In the normal intestine, kinetic
parameters demonstrated that ATMK treatment increased the maxi-
mal rate of uptake of Cl (Vmax for Cl−- uptake in BBMV was 98.6±
2.7nmol/mg protein min in normal+ATMK, n=3, p=0.01
(Fig. 2B), without a change in the afﬁnity of the transporter for Cl.
These data indicate that the mechanism of reversal of inhibition of
Cl−/HCO3− exchange by ATMK during chronic intestinal inﬂammation
was secondary to a restoration in the afﬁnity for Cl− rather than an
alteration in the number of BBM of Cl−/HCO3− exchangers.l and chronically inﬂamed rabbit ileum. Cl−/HCO3− exchange was signiﬁcantly inhibited
ﬂamed rabbit BBMV was reversed back to normal levels by ATMK treatment, n=5,
BBMV, n=5, *pb0.05.
Fig. 3. Effect of piroxicam treatment on Cl−/HCO3− exchange in villus cell BBMV from the
normal and chronically inﬂamed rabbit ileum. Cl−/HCO3− exchange that is inhibited dur-
ing chronic intestinal inﬂammation was reversed back to normal levels by piroxicam
treatment (1147±73 pmol/mg protein min in normal; 324±16* in inﬂamed and
1100±34* in inﬂamed+piroxicam, n=3, *pb0.001). Piroxicam treatment did not have
any effect on the normal rabbit BBMV (1037±33 pmol/mg protein min, n=3).
Fig. 2. Kinetics of Cl−/HCO3− exchange in villus cell BBMV from normal, inﬂamed and
ATMK treated rabbit ileum. HCO3−-dependent and DIDS-sensitive 36Cl uptake is
shown as a function of varying concentrations of extra vesicular Cl− at 3 secs. As
the concentration of extra-vesicular Cl− was increased, 36Cl uptake was stimulated
and subsequently became saturated in all conditions. Analysis of the data yielded ki-
netic parameters. A: In chronically inﬂamed BBMV the Cl−/HCO3− exchange was
inhibited by altering the afﬁnity of the transporter for Cl− and ATMK treatment sig-
niﬁcantly reversed the inhibited Cl−/HCO3− exchange in chronically inﬂamed villus
cell BBMV by restoring the afﬁnity of the transporter (Km) without an alteration in
the maximal rate of uptake (Vmax) of Cl, n=3. B: In normal rabbit villus cell BBMV
ATMK treatment stimulated Cl−/HCO3− exchange by altering the number of trans-
porters (Vmax), n=3.
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− exchange
Piroxicam, was utilized to inhibit cyclooxygenase (COX1 and COX2)
pathway in vivo in the chronically inﬂamed intestine. Piroxicam
reversed the inhibition of Cl−/HCO3− exchange in villus cell BBMV
(1147±73 pmol/mg protein min in normal; 324±16 in inﬂamed;
1037±33 in normal+piroxicam and 1100±34* in inﬂamed+
piroxicam, n=3, *pb0.01; Fig. 3). These data indicate that the COX
pathway likely mediates the inhibition of Cl−/HCO3− exchange during
chronic intestinal inﬂammation.Fig. 4. Effect of MK-886 treatment on Cl−/HCO3− exchange in villus cell BBMV from
chronically inﬂamed rabbit ileum. Cl−/HCO3− exchange that was inhibited during
chronic intestinal inﬂammation was not reversed by MK-886 treatment (324±16 in
inﬂamed and 411±46 in inﬂamed+MK-886, n=3, p=not signiﬁcant).3.4. Effect of inhibition of LOX pathway on Cl−/HCO3
− exchange
Since AA can be metabolized by the LOX pathway as well, MK-886
was utilized to inhibit this pathway. In vivo treatment of rabbits with
chronic intestinal inﬂammation with MK-886 did not reverse the di-
minished Cl−/HCO3−exchange in villus cell BBMV (Fig. 4). Thus,
these data indicate that inhibition of Cl−/HCO3− exchange during
chronic intestinal inﬂammation is not mediated by the LOX pathway.3.5. Kinetic studies for Cl−/HCO3
− exchange during inhibition of
COX pathway
To determine the mechanism of piroxicam-mediated reversal of in-
hibition of Cl−/HCO3− exchange in the chronically inﬂamed intestine, ki-
netics studies were performed. These data demonstrated that,
piroxicam did not alter the Vmax for Cl− uptake (Vmax for Cl− uptake
in BBMV was 47.5±2.2 nmol/mg protein. Min in normal, 42.8±2.8
in normal+piroxicam, 42.4±1.0 in inﬂamed and 45.1±1.8 in
inﬂamed+piroxicam; n=3). However, the afﬁnity for Cl− uptake,
which was reduced in the chronically inﬂamed rabbit intestine, was re-
stored by piroxicam treatment (Km for Cl− uptake in BBMVwas 19.0±
1.0 mM in normal, 43.3±1.8*inﬂamed, 20.5±2.5 normal+piroxicam,
and 23.1±1.2*inﬂamed+piroxicam; n=3, *pb0.05). Thus, these data
indicated that themechanism of reversal of inhibition of Cl−/HCO3− ex-
change by piroxicam during chronic intestinal inﬂammation was sec-
ondary to a restoration of the afﬁnity for Cl− rather than an increase
in transporter numbers.
3.6. Identiﬁcation of the Cl−/HCO3
− exchanger in rabbit ileum
BBMV–DRA
Different members of SLC26A protein familymaymediate Cl−/HCO3−
exchange depending upon their tissue distribution. In order to identify
Fig. 5. Relative abundance of anion exchangers in normal rabbit ileum by RTQ-PCR.
mRNA abundance is expressed relative to PAT1. Expression of mRNA levels of DRA
were 10 fold higher compared to PAT1 and Pendrin, n=3, *pb0.05.
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villus cells, RTQ-PCR for DRA (SLC26A3), PAT1 (SLC26A) and Pendrin
(SLC26A4) were performed. The results show that expression of DRA
was 10 fold higher than PAT1 or Pendrin in rabbit villus cells (Fig. 5).3.7. Immunocytochemistry studies of DRA
In order to localize DRA in the rabbit ileum and to investigate if it is
affected by chronic intestinal inﬂammation, immunocytochemistry was
performed. Fig. 6 demonstrates that DRA is present in the BBM of rabbit
small intestinal villus cells. Further, DRA protein expression was
unaltered during chronic intestinal inﬂammation. This is consistentFig. 6. Immunoﬂuorescence localization of DRA in rabbit ileum. A & B: Immunoﬂuorescent
pre-incubation of the antibody with antigenic peptide. C & D: Immunoﬂuorescence of DRAwith kinetic studies that Cl−/HCO3− exchange inhibition during chronic
inﬂammation is not secondary to a decrease in protein expression.
3.8. RTQ-PCR studies for DRA
Next to determine the molecular mechanism of COX mediated in-
hibition of DRA, we determined its mRNA abundance in villus cells by
RTQ-PCR. DRA speciﬁc mRNA abundance was not signiﬁcantly altered
in any condition (Fig. 7).
3.9. Western blot studies for DRA
Since mRNA level may not necessarily correlate with immunoreac-
tive protein in the BBM, we quantitated DRA speciﬁc immunoreactive
protein. There was no signiﬁcant difference in the immunoreactive
levels of DRA in any of the conditions tested (Fig. 8A). Densitometric
quantitation conﬁrmed these observations (Fig. 8B). These results, in
conjunction with kinetic parameters and RTQ-PCR data demonstrate
that the mechanism of inhibition of DRA by the COX pathway during
chronic intestinal inﬂammationwas secondary to a decrease in the afﬁn-
ity of the transporter for Cl− without a change in the transporter
numbers.
4. Discussion
This study demonstrated that in a mammalian animal model of IBD,
inhibition of coupledNaCl absorption occurs secondary to the inhibition
of Cl−/HCO3− but not, Na/H exchange in the BBM of absorptive villus
cells. This rabbit ileal villus cell BBM Cl−/HCO3− exchanger was identi-
ﬁed to be DRA. The inhibition of DRA in the chronically inﬂameddetection of DRA in rabbit ileum was performed using anti-DRA antibody following a
expression compared between normal and chronically inﬂamed rabbit ileum.
Fig. 7. RTQ-PCR analysis for DRA in rabbit ileum. DRA speciﬁc mRNA abundance was not
changed between normal, inﬂamed and piroxicam treated rabbit ileum, n=3, p=
insigniﬁcant.
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the metabolites of the cyclooxygenase, but not the lipoxygenase
pathway.
The most common and disabling morbidity of IBD is diarrhea
which is caused by malabsorption and secretion of electrolytes and
water
These electrolyte transport abnormalities are likely mediated by
immune-inﬂammatory mediators known to be elevated in the muco-
sa of the chronically inﬂamed intestine [26–28]. Given that treat-
ments for IBD are few and fraught with numerous side effects, it is
necessary to more clearly deﬁne which immune inﬂammatory medi-
ators affect electrolyte absorption so a more precise treatment can be
developed with fewer side effects. Therefore, this study was designed
to begin to determine which immune inﬂammatory mediators regu-
late coupled NaCl absorption, speciﬁcally Cl−/HCO3−exchange, in the
chronically inﬂamed intestine.
In previous studies we had demonstrated that Cl−/HCO3−ex-
change was inhibited in the BBM of villus cells from the chronically
inﬂamed rabbit intestine. The mechanism of inhibition was secondary
to a reduction in the afﬁnity of the transporter for Cl without a change
in the number of transporters in the BBM. However, the molecular
identity of this Cl−/HCO3−exchanger in the rabbit intestine was un-
known. This study demonstrated that DRA mediates Cl−/HCO3−Fig. 8.Western blot analysis for DRA in rabbit ileum. A: DRA speciﬁc protein expression
was not altered between normal, inﬂamed and piroxicam treated rabbit ileum. B: Den-
sitometric analysis shows the relative expression of DRA protein levels in all the differ-
ent experimental condition with reference to its level in villus cell BBM from normal
intestine, n=3, p=insigniﬁcant.exchange in rabbit ileal villus cells. This observation is different
from that in mouse where PAT1 is the major Cl−/HCO3− exchanger
expressed in BBM of the small intestine [3,37], while DRA is abun-
dantly expressed in apical membranes of colonocytes [3,38]. Despite
the low expression of DRA in the small intestine, functional studies
have shown that DRA is the major Cl−/HCO3− exchanger coupled
with NHE3 for electro neutral NaCl absorption in murine small intes-
tine [39]. In contrast to mouse, RTQ-PCR studies showed that expres-
sion of mRNA of DRA was 10 fold higher compared to PAT1 and
Pendrin in the rabbit small intestine (Fig. 5). Consistent with
RTQ-PCR data, immunocytochemistry and Western blot studies
showed that DRA was indeed the predominant anion exchanger in
the BBM of villus cells in the rabbit ileum (Fig. 6). Thus, these data
clearly indicate that DRA mediates Cl−/HCO3− exchange in villus
cells in the rabbit small intestine. Other studies have demonstrated
the role of DRA in the causation of diarrhea. Mutation in DRA causes
congenital chloride diarrhea both in patients and experimental ani-
mal models [40,41] and loss of transporter function of DRA plays a
crucial role in the pathogenesis of diarrhea in intestinal inﬂammation
[42].
The inhibition of DRA in the chronically inﬂamed rabbit intestine
is likely mediated by immune-inﬂammatory mediators known to be
elevated in the mucosa. We previously reported that a variety of
immune-inﬂammatory mediators including prostaglandins and leu-
kotrienes are markedly increased in the mucosa of the chronically
inﬂamed rabbit intestine [35]. Further, previous studies have demon-
strated that these agents likely mediate multiple unique alterations in
electrolyte, Na-nutrient and Na-bile acid transporters during chronic
intestinal inﬂammation [1,15,16,29,30]. For example Na-glucose
co-transporter was inhibited by a decrease in the number of co-
transporter [16] while Na-alanine co-transporter was inhibited by a
reduction in the afﬁnity for amino acid [15]. Our in vitro studies
have demonstrated that prostaglandin E2 (PGE2), a cyclooxygenase
pathway metabolite, inhibits Na-glucose co-transport while leukotri-
ene D4 (LTD4), a 5-lipoxygenase pathway metabolite, was responsi-
ble for inhibition Na-alanine co-transport in IEC-18 cells [36].
That DRA inhibition in the chronically inﬂamed rabbit intestine is
likely mediated by immune inﬂammatory mediators as well is
supported by our previous observation that broad spectrum immune
modulation alleviated this inhibition. Glucocorticoid ethylprednisolone
is a common treatment for IBD and as a nonspeciﬁc immunemodulator
known to blockmultiple pathways of the immune system including the
arachidonic acid metabolite cascade. Further, as a broad spectrum
immune modulator, glucocorticoid treatment of IBD has been shown
to alleviate the inhibition of Cl−/HCO3−exchange as well as other trans-
porters [31–34]. Nevertheless, more speciﬁc immune mechanism of
regulation of Cl−/HCO3−exchange in the chronically inﬂamed intestine
was not well understood.
In chronically inﬂamed rabbit intestine, speciﬁc inhibition of the
formation arachidonic acid reversed the inhibition of Cl−/HCO3− ex-
change activity, Kinetic studies showed that the mechanism of rever-
sal of Cl−/HCO3− exchange by ATMK treatment was secondary to
restoration in the afﬁnity of the transporter for Cl− without affecting
transporter number (Vmax) in chronically inﬂamed rabbit ileum.
These results indicate that AAM mediate the inhibition of Cl−/HCO3−
exchange during chronic enteritis Interestingly, ATMK treatment
stimulated Cl−/HCO3− exchange in the normal intestine and the
mechanism of stimulation was secondary to an increase in exchanger
numbers in the BBM. This mechanism of regulation of Cl−/HCO3− ex-
change appears to be lost in the chronically inﬂamed intestine. It may
be that AAM produced in the normal intestine have a baseline inhib-
itory effect on this exchanger which is alleviated by ATMK. Future
studies will need to further elucidate this ﬁnding.
Since AAM produced by both the COX and/or LOX pathways are
known to be elevated in the chronically inﬂamed intestine, each path-
waywas selectively inhibited to determinewhich speciﬁcally mediated
185P. Manoharan et al. / Biochimica et Biophysica Acta 1828 (2013) 179–186the inhibition of Cl−/HCO3− exchange. It was demonstrated that the cy-
clooxygenase inhibitor piroxicam reversed the Cl−/HCO3− exchange
while 5-lipoxygenase inhibitor MK-886 did not have an effect on
Cl−/HCO3− exchange during chronic intestinal inﬂammation. This indicat-
ed that during chronic intestinal inﬂammation, Cl−/HCO3− exchange is
regulated by immune inﬂammatory mediators produced by the cycloox-
ygenase but not, the 5-lipoxygenase pathway. Other investigators have
also shown the importance of DRA regulation by immune inﬂammatory
mediators. For example, Saksena et al., have demonstrated that IFN-γ sig-
niﬁcantly inhibited DRA gene expression and promoter activity in Caco-2
cells. The inhibition ofDRAwasmediated by signal transducer and activa-
tor of transcription factor 1 (STAT1) [43,44]. Therefore, delineating the
pathway responsible for alteration of coupledNaCl absorption by altering
DRA may yield precise targeted therapies for patients with IBD.
The COX pathwaymediated alteration of Cl−/HCO3− exchange at the
molecular level appears to be post translational. RTQ-PCR and Western
blot studies showed that there was no change in DRA speciﬁc mRNA
abundance and protein expression respectively in the chronically in-
ﬂamed intestine(Figs. 7 and 8). Immunocytochemistry studies also
showed there was no difference in expression of DRA between normal
and inﬂamed rabbit villus cell BBM (Fig. 6C and D). Further, both
ATMK and piroxicam treatment reversed the inhibited Cl−/HCO3− ex-
change by restoring the afﬁnity of the transporter. Thus, together our
functional andmolecular data demonstrate that themechanism of inhi-
bition of DRA is post translational during chronic enteritis. The alter-
ation in the afﬁnity of the DRA for Cl− during chronic ileitis may be
due to changes in glycosylation and/or phosphorylation of the trans-
porter since they are themost common post translational modiﬁcations
observed in membrane proteins.
In conclusion, this study demonstrates that DRA is the primary villus
cell BBM Cl−/HCO3− exchanger in the rabbit intestine. It is inhibited sec-
ondary to a reduction in the afﬁnity of the transporter for Cl in the
chronically inﬂamed intestine. This inhibition of DRA ismediated by ar-
achidonic acid metabolites during chronic enteritis. Finally, cyclooxy-
genase but not the 5-lipoxygenase pathway metabolites mediate the
inhibition of DRA during chronic intestinal inﬂammation.
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